Maria A. Lopez-Olivo, MD, PhD

The University of Texas, MD Anderson Cancer Center
Houston, TX, United States

Dr. Lopez-Olivo is a medical scientist with expertise in knowledge synthesis and translational research. She has conducted several systematic reviews of drug therapies for the Cochrane Collaboration and has experience in the translation of evidence into educational tools to inform patients and facilitate decision-making. Her research interests include development and implementation of innovative learning programs on comparative effectiveness research.

Disclosure information not submitted.

Presentation(s):

• 0202: Learning Needs Assessment for Patients with Cancer and a Pre-Existing Autoimmune Disease Who Are Candidates to Receive Immune Checkpoint Inhibitors

  Saturday, November 12, 2022
  1:00 PM – 3:00 PM Eastern Time

• 1349: Priority Educational Topics to Deliver Information About Immune Checkpoint Inhibitors for Patients with Cancer and a Pre-Existing Autoimmune Disease

  Sunday, November 13, 2022
  1:00 PM – 3:00 PM Eastern Time